You have 6 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Nonmyeloablative allo-HSCT

Showing 26 - 50 of 1,303
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

CNS Leukemia, Allogeneic Hematopoietic Stem Cell Transplantation Trial in Xi'an (TBF regimen, modified BuCY2 regimen)

Not yet recruiting
  • Central Nervous System Leukemia
  • Allogeneic Hematopoietic Stem Cell Transplantation
  • TBF regimen
  • modified BuCY2 regimen
  • Xi'an, Shaanxi, China
    First Affiliated Hospital of Xi'an Jiaotong University
Dec 26, 2022

Acute Myeloid Leukemia Trial (Azacitidine, Donor lymphocyte infusion, Camrelizumab)

Not yet recruiting
  • Acute Myeloid Leukemia
  • (no location specified)
Mar 15, 2023

CMV Infection, EBV Infection, Stem Cell Transplant Trial (Virus specific T cells)

Not yet recruiting
  • CMV Infection
  • +2 more
  • Virus specific T cells
  • (no location specified)
Oct 4, 2023

Donor COVID-19 Infection Status on the Recipient in Allo-HSCT

Recruiting
  • COVID-19
  • Hematopoietic Stem Cell Transplantation
    • Suzhou, Jiangsu, China
      First Affiliated Hospital of Soochow University
    Jan 10, 2023

    Acute Leukemia Trial in Suzhou (mitoxantrone liposome, ATG)

    Recruiting
    • Acute Leukemia
    • mitoxantrone liposome
    • ATG
    • Suzhou, Jiangsu, China
      The First Affiliated Hospital of Soochow University
    Feb 13, 2023

    AML Trial in Moscow (allo-HSCT)

    Recruiting
    • AML
    • allo-HSCT
    • Moscow, Russian Federation
      National Research Center for Hematology
    Apr 14, 2022

    Hypomethylating Agent, Venetoclax, Myeloid Malignancy Trial in Shanghai (Venetoclax, Azacitidine or decitabine)

    Recruiting
    • Hypomethylating Agent
    • +2 more
    • Shanghai, Shanghai, China
      Shanghai Jiao Tong University School of Medicine Affilated Shang
    May 2, 2023

    MPS-IH (Hurler Syndrome) Trial in Worldwide (Experimental: OTL-203, Active Comparator: Allo-HSCT)

    Not yet recruiting
    • MPS-IH (Hurler Syndrome)
    • Experimental: OTL-203
    • Active Comparator: Allo-HSCT
    • Oakland, California
    • +6 more
    Nov 27, 2023

    Digital Droplet PCR in Early Period After Allo-HSCT to Predict

    Completed
    • Measurable Residual Disease
    • Digital Droplet PCR
    • Hangzhou, Zhejiang, China
      The First Hospital of Zhejiang Medical Colleage Zhejiang Univers
    Aug 17, 2023

    Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, MDS Trial in Beijing (Ex-vivo expanded ?d T cell infusion)

    Recruiting
    • Acute Myeloid Leukemia
    • +3 more
    • Ex-vivo expanded γδ T cell infusion
    • Beijing, China
      Chinese PLA General Hospital
    Mar 24, 2022

    Adult Acute Myeloid Leukemia Trial (mocravimod)

    Not yet recruiting
    • Adult Acute Myeloid Leukemia
    • (no location specified)
    Jun 27, 2022

    T Lymphoblastic Leukemia/Lymphoma Trial in Hangzhou (Chidamide)

    Recruiting
    • T Lymphoblastic Leukemia/Lymphoma
    • Hangzhou, Zhejiang, China
      The First Hospital of Zhejiang Medical Colleage Zhejiang Univers
    Aug 7, 2023

    Intensive Conditioning With Thiotepa Combined With Bu/Flu/Ara-C

    Not yet recruiting
    • Acute Myeloid Leukemia
    • +4 more
      • (no location specified)
      Nov 1, 2023

      Acute Myelogenous Leukemia (AML), Myelodysplastic Syndrome (MDS) Trial in Minneapolis (N-803)

      Completed
      • Acute Myelogenous Leukemia (AML)
      • Myelodysplastic Syndrome (MDS)
      • Minneapolis, Minnesota
        Masonic Cancer Center at University of Minnesota
      Jan 4, 2023

      Mucopolysaccharidosis Type IH (MPS IH, Hurler Syndrome), Mucopolysaccharidosis Type IH, MPS IH, Hurler Syndrome Trial

      Withdrawn
      • Mucopolysaccharidosis Type IH (MPS IH, Hurler Syndrome)
      • +2 more
      • Autologous Plasmablasts
      • (no location specified)
      Oct 5, 2022

      Myeloid Leukemia, Acute Trial in France (Bone osteodensitometry)

      Not yet recruiting
      • Myeloid Leukemia, Acute
      • Bone osteodensitometry
      • Amiens, France
      • +3 more
      Dec 6, 2021

      AML - Acute Myeloid Leukemia, MDS (Myelodysplastic Syndrome), Mixed Phenotype Acute Leukemia Trial in Palo Alto (T-allo10)

      Recruiting
      • AML - Acute Myeloid Leukemia
      • +5 more
      • T-allo10
      • Palo Alto, California
        Lucile Packard Children's Hospital
      Feb 2, 2022

      Cytarabine+Thiotepa + Fludarabine + Busulfan, T Cell Acute Lymphoblastic Leukemia/Lymphoblastic Lymphoma Trial in Hangzhou

      Recruiting
      • Cytarabine+Thiotepa + Fludarabine + Busulfan
      • T Cell Acute Lymphoblastic Leukemia/Lymphoblastic Lymphoma
      • cytarabine+thiotepa+ fludarabine + busulfan
      • Hangzhou, China
        The First Affiliated Hospital, College of Medicine, Zhejiang Uni
      Oct 26, 2022

      Aplastic Anemia Trial in Suzhou (CD20 mAb, ATG)

      Recruiting
      • Aplastic Anemia
      • CD20 monoclonal antibody
      • ATG
      • Suzhou, Jiangsu, China
        The First Affiliated Hospital of Soochow University
      Aug 21, 2022

      SCD Curative Therapies

      Not yet recruiting
      • Sickle Cell Disease
      • +3 more
        • Washington, District of Columbia
        • +4 more
        Jun 28, 2022

        Myelodysplastic Syndrome, Allogeneic Hematopoietic Stem Cell Transplantation, Conditioning Trial in Guangzhou (Granulocyte

        Recruiting
        • Myelodysplastic Syndrome
        • +2 more
        • Granulocyte Colony-Stimulating Factor(G-CSF)
        • +5 more
        • Guangzhou, Guangdong, China
          Department of Hematology,Nanfang Hospital, Southern Medical Univ
        Jul 11, 2022

        Secondary Acute Myeloid Leukemia Evolving From MDS, Allogeneic Hematopoietic Stem Cell Transplantation, Conditioning Trial in

        Recruiting
        • Secondary Acute Myeloid Leukemia Evolving From MDS
        • +2 more
        • Granulocyte Colony-Stimulating Factor(G-CSF)
        • +4 more
        • Guangzhou, Guangdong, China
          Department of Hematology,Nanfang Hospital, Southern Medical Univ
        Jul 5, 2022

        PLT After Allogenic Hematopoietic Stem Cell Transplantation Trial (Avatrombopag, rhTPO)

        Not yet recruiting
        • PLT After Allogenic Hematopoietic Stem Cell Transplantation
        • (no location specified)
        Nov 21, 2021

        B-cell Acute Lymphoblastic Leukemia Trial in Suzhou (Blinatumomab, Conventional therapy)

        Recruiting
        • B-cell Acute Lymphoblastic Leukemia
        • Suzhou, Jiangsu, China
          The first affiliated hospital of Soochow University
        Sep 26, 2022

        Acute Myelogenous Leukemia, Acute Lymphocytic Leukemia, Biphenotypic Acute Leukemia Trial in Minneapolis (biological, drug,

        Not yet recruiting
        • Acute Myelogenous Leukemia
        • +17 more
        • Peripheral Blood Stem Cell Transplant
        • +7 more
        • Minneapolis, Minnesota
          Masonic Cancer Center at University of Minnesota
        Mar 27, 2023